Litigation Details for IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. (D.N.J. 2017)
✉ Email this page to a colleague
IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. (D.N.J. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-12-21 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 15:1126 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | |
| Patents | 8,377,474; 9,089,608 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. (D.N.J. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-07-25 | 145 | component” in various claims in U.S. Patent No. 8,377,474 (the “’474 patent”) and found that, during prosecution…collectively, “Zydus”). In this patent infringement suit involving a pharmaceutical patent, the parties seek construction…construction of a claim term in U.S. Patent No. 9,089,608 (“the ’608 patent”). The parties dispute … attaches to the patent and then spreads to every limb and leaf in the family patent tree. It is not …prosecution of the ‘474 patent, cannot, 1 Zydus claims that the claims in the ‘474 patent also contained | External link to document | |
| 2020-03-23 | 211 | Order on Motion in Limine | from a patent infringement dispute involving a pharmaceutical patent, U.S. Patent No. 9,089,608 (“the …the ’608 patent”). Claim 21 of this patent is at issue. The preamble of claim 21 states: “A controlled… 1 contention that the patent is void for indefiniteness. The parties…December 2017 2:17-cv-13476-SRC-CLW Patent - Abbreviated New Drug Application(ANDA) | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
